Army medical developers showcase latest in health care tech, capabilities during AUSA Expo in Nation’s Capital [Image 19 of 20]

WASHINGTON, DC, UNITED STATES

10.11.2023

Photo by T. T. Parish 

U.S. Army Medical Materiel Development Activity (USAMMDA)

U.S. Army Col. Slavomir Bilinski, left, chief of the Chemical Casualty Care Division with the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), speaks with U.S. Army Brig. Gen. Edward H. Bailey, commanding general of the U.S. Army Medical Research and Development Command (USAMRDC) during the Association of the United States Army (AUSA) 2023 Annual Meeting and Exposition inside the Walter E. Washington Convention Center, Washington, Oct. 11, 2023. During AUSA, team members with the U.S. Army Medical Materiel Development Activity (USAMMDA), USAMRICD, U.S. Army Research Institute of Environmental Medicine (USARIEM), and USAMRDC met and spoke with attendees visiting the U.S. Army Medical Command (MEDCOM) exhibit. USAMMDA, the U.S. Department of Defense's lead medical product development activity, develops new drugs, vaccines, devices, and medical support equipment designed to enhance Joint Force readiness and maximize survival of medical casualties on the battlefield. (U.S. Army Photo by T. T. Parish/Released)

• Date Taken: 10.11.2023
• Date Posted: 10.12.2023 13:30
• Photo ID: 8067940
• VIRIN: 231011-A-PJ332-1204
• Resolution: 5112x3408
• Size: 12.35 MB
• Location: WASHINGTON, DC, US